API particle size governs in situ forming implant formation, microstructure evolution and performance
- 5 May 2026
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 698, 126951
Abstract
No abstract availableKeywords
Funding Information
- University of Connecticut
- U.S. Food and Drug Administration (75F40123C00142)
This publication has 23 references indexed in Scilit:
- In vivo characterization of Perseris and compositionally equivalent formulationsInternational Journal of Pharmaceutics, 2023
- Reverse engineering of Perseris and development of compositionally equivalent formulationsInternational Journal of Pharmaceutics, 2023
- Novel adapter method for in vitro release testing of in situ forming implantsInternational Journal of Pharmaceutics, 2022
- Drug release from in situ forming implants and advances in release testingAdvanced Drug Delivery Reviews, 2021
- Effect of implant formation on drug release kinetics of in situ forming implantsInternational Journal of Pharmaceutics, 2021
- Clinically established biodegradable long acting injectables: An industry perspectiveAdvanced Drug Delivery Reviews, 2020
- Preparation of Thin Frozen Sections from Nonfixed and Undecalcified Hard Tissues Using Kawamoto’s Film Method (2020)2020
- Preparation of Thin Frozen Sections from Nonfixed and Undecalcified Hard Tissues Using Kawamot’s Film Method (2012)2014
- Biodegradable poly(polyol sebacate) polymersBiomaterials, 2008
- A method for preparing 2- to 50-µm-thick fresh-frozen sections of large samples and undecalcified hard tissuesHistochemistry and Cell Biology, 2000